PREVALENCE OF FATIGUE AND IMPACT ON QUALITY OF LIFE IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: the VITAL study

BACKGROUND: Fatigue is one of the most prevalent symptoms among cancer patients. Specifically, in metastatic castration-resistant prostate cancer (mCRPC) patients, fatigue is the most common adverse event associated with current treatments. The purpose of this study is to describe the prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez Antolín, A., Martínez-Piñeiro, L., Jiménez Romero, M. E., García Ramos, J. B., López Bellido, D., Muñoz del Toro, J., García García-Porrero, A., Gómez Veiga, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796370/
https://www.ncbi.nlm.nih.gov/pubmed/31619215
http://dx.doi.org/10.1186/s12894-019-0527-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796370/
https://www.ncbi.nlm.nih.gov/pubmed/31619215
http://dx.doi.org/10.1186/s12894-019-0527-8

Ejemplares similares